阿科力(603722.SH)三天兩板:目前COC/COP產品處於研發過程中 尚未量產
格隆匯 7 月 27日丨阿科力(603722.SH)公佈,公司股票交易連續三個交易日(2020年7月23日、2020年7月24日、2020年7月27日)內收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動情形。
經公司自查,公司目前生產經營活動正常,主營業務未發生重大調整或變化。公司主要產品為脂肪胺、光學材料,2020年第一季度脂肪胺營收佔比為64.51%。
公司注意到近期有媒體報道稱公司COC/COP產品可運用於生產疫苗瓶。公司在此澄清:目前公司COC/COP產品處於研發過程中,尚未量產,目前對公司的主要財務數據無重大影響。COC/COP材料能否應用於生產疫苗瓶還有待驗證,相關事項存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.